Dr. Aiyar's holdings in Korro Bio reflect significant confidence in the company's future, with insider trading activity showcasing ups and downs in stock value. His stake was valued at $6.21 million in November 2023 and peaked at $11.43 million by...

Dr. Aiyar's holdings in Korro Bio reflect significant confidence in the company's future, with insider trading activity showcasing ups and downs in stock value. His stake was valued at $6.21 million in November 2023 and peaked at $11.43 million by April 2024. This increase suggests positive market reactions to the company’s strategies and developments. His holdings illustrate a personal investment in the company's mission, aligning his financial success with Korro's growth. With a base salary of $498,487, Aiyar has significant incentives linked to performance metrics, reflecting a commitment to enhancing shareholder value in the rapidly evolving biopharmaceutical landscape. Investing in Korro’s shares is indicative of both personal confidence and strategic foresight in a competitive marketplace.